A Phase I, Open Label, Dose Escalation And Cohort Expansion Study To Evaluate The Safety And Immune Response To Autologous Dendritic Cells (Dc) Transduced With Adgmca9 (Dc-Adgmcaix) In Patients With Mrcc.
JOURNAL OF CLINICAL ONCOLOGY（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要